{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:34:33Z","timestamp":1785350073111,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23fk0210097h0003"],"award-info":[{"award-number":["JP23fk0210097h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbamcr.2025.120000","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T11:48:40Z","timestamp":1749469720000},"page":"120000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recombinant human ADAMTS13 attenuates LPS-induced acute kidney injury and renal microangiopathy in murine advanced liver fibrosis by cleaving vWF"],"prefix":"10.1016","volume":"1872","author":[{"given":"Hiroyuki","family":"Masuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihisa","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Takami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Shibamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Takaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Namisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Yoshiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2025.120000_bb0005","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/j.gastro.2023.11.306","article-title":"Hepatorenal syndrome in cirrhosis","volume":"166","author":"Pose","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbamcr.2025.120000_bb0010","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMra2215289","article-title":"Acute kidney injury in patients with cirrhosis","volume":"388","author":"Nadim","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/j.akdh.2024.01.002","article-title":"Pathophysiology of Hepatorenal syndrome","volume":"31","author":"Velez","year":"2024","journal-title":"Adv. Kidney. Dis. Health."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0020","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/ndt\/gfx354","article-title":"Role of the cytochrome P-450\/ epoxyeicosatrienoic acids pathway in the pathogenesis of renal dysfunction in cirrhosis","volume":"33","author":"Yeboah","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0025","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/liv.12263","article-title":"The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives","volume":"33","author":"Baldassarre","year":"2013","journal-title":"Liver Int."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/157488408785747728","article-title":"Vasopressin in liver disease--should we turn on or off?","volume":"3","author":"Lo","year":"2008","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.bbamcr.2025.120000_bb0040","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/liv.14037","article-title":"Characterization of inflammatory response in hepatorenal syndrome: relationship with kidney outcome and survival","volume":"39","author":"Sol\u00e9","year":"2019","journal-title":"Liver Int."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0045","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.bbamcr.2025.120000_bb0050","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0055","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0060","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000526","article-title":"Incidence and type of adverse events in patients with cirrhosis receiving terlipressin: a systematic review and meta-analysis","volume":"8","author":"Shang","year":"2024","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021587","article-title":"Phenotypic expression of ADAMTS13 in glomerular endothelial cells","volume":"6","author":"Tati","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2025.120000_bb0070","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/j.1538-7836.2006.01959.x","article-title":"Human endothelial cells synthesize and release ADAMTS-13","volume":"4","author":"Turner","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0075","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1182\/blood-2005-01-0152","article-title":"Localization of ADAMTS13 to the stellate cells of human liver","volume":"106","author":"Uemura","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2025.120000_bb0080","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1182\/blood-2003-03-0908","article-title":"ADAMTS-13 cysteine-rich\/spacer domains are functionally essential for von Willebrand factor cleavage","volume":"102","author":"Soejima","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2025.120000_bb0085","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0090","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood-2011-09-376202","article-title":"ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice","volume":"119","author":"Gandhi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2025.120000_bb0095","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.thromres.2014.03.024","article-title":"High shear dependent von Willebrand factor self-assembly fostered by platelet interaction and controlled by ADAMTS13","volume":"133","author":"Kragh","year":"2014","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.100945","article-title":"Advances in the management of TTP","volume":"55","author":"Subhan","year":"2022","journal-title":"Blood Rev."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0105","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3390\/jcm11071835","article-title":"ADAMTS13, VWF, and endotoxin are interrelated and associated with the severity of liver cirrhosis via hypercoagulability","volume":"11","author":"Takaya","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0110","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s10620-023-08257-w","article-title":"VWF\/ADAMTS13 ratio as a potential predictive biomarker for acute kidney injury onset in cirrhosis","volume":"69","author":"Asada","year":"2024","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0115","unstructured":"Takami, M., Nishimura, N., Kaji, K., Yorioka, N., Masuda, H., Takaya, H., Kitagawa, K., Sato, S., Namisaki, T., Yoshiji, H. Involvement of the ADAMTS13\/von Willebrand factor axis in acute kidney injury in mice with liver cirrhosis. Hepatol. Res. (n.d.)."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0120","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1056\/NEJMoa2314793","article-title":"cTTP phase 3 study investigators, recombinant ADAMTS13 in congenital thrombotic thrombocytopenic Purpura","volume":"390","author":"Scully","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0125","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007004","article-title":"Recombinant human ADAMTS13 treatment improves myocardial remodeling and functionality after pressure overload injury in mice","volume":"7","author":"Witsch","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0130","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1182\/blood-2009-03-213264","article-title":"von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke","volume":"114","author":"Zhao","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2025.120000_bb0135","doi-asserted-by":"crossref","first-page":"14453","DOI":"10.1038\/s41598-019-51013-2","article-title":"Functional regulation of von Willebrand factor ameliorates acute ischemia-reperfusion kidney injury in mice","volume":"9","author":"Ono","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0140","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2019.11.013","article-title":"Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice","volume":"72","author":"Xiang","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0145","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/hepr.13879","article-title":"Navitoclax improves acute-on-chronic liver failure by eliminating senescent cells in mice","volume":"53","author":"Watanabe","year":"2023","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0150","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1600-6143.2009.02621.x","article-title":"Development of a severe von Willebrand factor\/ADAMTS13 dysbalance during orthotopic liver transplantation","volume":"9","author":"Pereboom","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0155","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/ijlh.13107","article-title":"Semi-automated von Willebrand factor multimer assay for von Willebrand disease: further validation, benefits and limitations","volume":"41","author":"Oliver","year":"2019","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0160","doi-asserted-by":"crossref","first-page":"H861","DOI":"10.1152\/ajpheart.00640.2005","article-title":"Differential sympathetic outflow and vasoconstriction responses at kidney and skeletal muscles during fictive locomotion","volume":"290","author":"Koba","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0165","doi-asserted-by":"crossref","first-page":"861","DOI":"10.4049\/jimmunol.2100481","article-title":"The protective role of IL-36\/IL-36R signal in con A-induced acute hepatitis","volume":"208","author":"Wang","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0170","doi-asserted-by":"crossref","first-page":"2356023","DOI":"10.1080\/0886022X.2024.2356023","article-title":"Glycyrrhizin attenuates renal inflammation in a mouse con A-hepatitis model via the IL-25\/M2 axis","volume":"46","author":"Li","year":"2024","journal-title":"Ren. Fail."},{"issue":"3","key":"10.1016\/j.bbamcr.2025.120000_bb0175","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3748\/wjg.v17.i3.322","article-title":"Effect of heme oxygenase-1 on renal function in rats with liver cirrhosis","volume":"17","author":"Guo","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0180","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/jth.15312","article-title":"Targeting von Willebrand factor in liver diseases: a novel therapeutic strategy?","volume":"19","author":"Groeneveld","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0185","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/hep.25806","article-title":"von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis","volume":"56","author":"Ferlitsch","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bbamcr.2025.120000_bb0190","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V98.9.2730","article-title":"Changes in health and disease of the metalloprotease that cleaves von Willebrand factor","volume":"98","author":"Mannucci","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2025.120000_bb0195","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s12072-023-10577-y","article-title":"Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome","volume":"17","author":"Simbrunner","year":"2023","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0200","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/759047","article-title":"Determination of ADAMTS13 and its clinical significance for ADAMTS13 supplementation therapy to improve the survival of patients with decompensated liver cirrhosis","volume":"2011","author":"Uemura","year":"2011","journal-title":"Int. J. Hepatol."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/liv.12657","article-title":"Imbalance of von Willebrand factor and its cleaving protease ADAMTS13 during systemic inflammation superimposed on advanced cirrhosis","volume":"35","author":"Reuken","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0210","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.toxrep.2014.09.001","article-title":"Acute liver injury induced by low dose dimethylnitrosamine alters mediators of hepatic vascular flow","volume":"1","author":"Amirtharaj","year":"2014","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0215","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1055\/s-0038-1636529","article-title":"Von Willebrand factor aggravates hepatic ischemia-reperfusion injury by promoting neutrophil recruitment in mice","volume":"118","author":"Urisono","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0220","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/ATVBAHA.117.309539","article-title":"ADAMTS13 retards progression of diabetic nephropathy by inhibiting intrarenal thrombosis in mice","volume":"37","author":"Dhanesha","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0225","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mvr.2012.05.004","article-title":"ADAMTS13 promotes angiogenesis and modulates VEGF-induced angiogenesis","volume":"84","author":"Lee","year":"2012","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0230","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2010-01-264507","article-title":"Endothelial von Willebrand factor regulates angiogenesis","volume":"117","author":"Starke","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2025.120000_bb0235","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4103\/cjop.CJOP-D-23-00101","article-title":"ADAMTS13 inhibits H2O2-induced human venous endothelial cell injury to attenuate deep-vein thrombosis by blocking the p38\/ERK signaling pathway","volume":"66","author":"Zheng","year":"2023","journal-title":"Chin. J. Physiol."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0240","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.freeradbiomed.2019.11.027","article-title":"Cannabinoid-2 receptor activation ameliorates hepatorenal syndrome","volume":"152","author":"Trojnar","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0245","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/j.1538-7836.2012.04822.x","article-title":"ADAMTS13 reduces VWF-mediated acute inflammation following focal cerebral ischemia in mice","volume":"10","author":"Khan","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0250","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1182\/blood-2012-06-440255","article-title":"ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia\/reperfusion injury in mice","volume":"120","author":"Gandhi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2025.120000_bb0255","doi-asserted-by":"crossref","first-page":"F134","DOI":"10.1152\/ajprenal.00405.2018","article-title":"ADAMTS13 protects mice against renal ischemia-reperfusion injury by reducing inflammation and improving endothelial function","volume":"316","author":"Zhou","year":"2019","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0260","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6193694","article-title":"Oxidative stress and acute kidney injury in critical illness: pathophysiologic mechanisms-biomarkers-interventions, and future perspectives","volume":"2017","author":"Pavlakou","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0265","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/toxins12090567","article-title":"Two toxic lipid aldehydes, 4-hydroxy-2-hexenal (4-HHE) and 4-hydroxy-2-nonenal (4-HNE), accumulate in patients with chronic kidney disease","volume":"12","author":"Soulage","year":"2020","journal-title":"Toxins (Basel)."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0270","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5937326","article-title":"4-Hydroxy-Trans-2-Nonenal in the regulation of anti-oxidative and pro-inflammatory signaling pathways","volume":"2019","author":"Sonowal","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0275","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13586","article-title":"ADAMTS13 inhibits oxidative stress and ameliorates progressive chronic kidney disease following ischaemia\/reperfusion injury","volume":"231","author":"Zhou","year":"2021","journal-title":"Acta Physiol. (Oxf.)."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0280","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jhep.2009.11.025","article-title":"The evaluation of renal function and disease in patients with cirrhosis","volume":"52","author":"Francoz","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbamcr.2025.120000_bb0285","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jhep.2016.12.005","article-title":"The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction","volume":"66","author":"Schwabl","year":"2017","journal-title":"J. Hepatol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488925001053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488925001053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T07:28:51Z","timestamp":1754465331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488925001053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0167488925001053"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2025.120000","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant human ADAMTS13 attenuates LPS-induced acute kidney injury and renal microangiopathy in murine advanced liver fibrosis by cleaving vWF","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2025.120000","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120000"}}